{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:31:59Z","timestamp":1786480319994,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.34067\/kid.0000000679","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T17:00:08Z","timestamp":1734109208000},"page":"892-894","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Tight Phosphate Control in ESKD Patients Is Warranted: PRO"],"prefix":"10.34067","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4556-3320","authenticated-orcid":false,"given":"Ryan M.","family":"Song","sequence":"first","affiliation":[{"name":"Division of Nephrology, University of Chicago Pritzker School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3330-0179","authenticated-orcid":false,"given":"Stuart M.","family":"Sprague","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, NorthShore University Health System-Endeavor Health, Pritzker School of Medicine, University of Chicago, Evanston, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"issue":"2","key":"B1-20250626","doi-asserted-by":"crossref","first-page":"100584","DOI":"10.1016\/j.xkme.2022.100584","article-title":"Serum phosphorus level rises in US hemodialysis patients over the past decade: a DOPPS special report","volume":"5","author":"Guedes","year":"2023","journal-title":"Kidney Med."},{"issue":"4","key":"B2-20250626","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders in mineral metabolism with progression of chronic kidney disease","volume":"1","author":"Schwarz","year":"2006","journal-title":"Clin J Am Soc Nephrol."},{"issue":"11","key":"B3-20250626","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/toxins11110647","article-title":"FGF23 and phosphate\u2013cardiovascular toxins in CKD","volume":"11","author":"Vogt","year":"2019","journal-title":"Toxins."},{"issue":"12","key":"B4-20250626","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"issue":"4","key":"B5-20250626","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/ndt\/gfad190","article-title":"Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients","volume":"39","author":"Barrera-Baena","year":"2024","journal-title":"Nephrol Dial Transplant."},{"issue":"11","key":"B6-20250626","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"J Am Med Assoc."},{"issue":"10","key":"B7-20250626","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/ndt\/gfaa054","article-title":"Impact of longer term phosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS","volume":"35","author":"Lopes","year":"2020","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"B8-20250626","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1681\/ASN.2020050598","article-title":"Optimal phosphate control related to coronary artery calcification in dialysis patients","volume":"32","author":"Isaka","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"11","key":"B9-20250626","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.5551\/jat.64159","article-title":"Clinical implication of consistently strict phosphate control for coronary and valvular calcification in incident patients undergoing hemodialysis","volume":"30","author":"Shimizu","year":"2023","journal-title":"J Atheroscler Thromb."},{"issue":"11","key":"B10-20250626","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.34067\/KID.0000000000000280","article-title":"Tenapanor improves long-term control of hyperphosphatemia in patients receiving maintenance dialysis: the NORMALIZE Study","volume":"4","author":"Silva","year":"2023","journal-title":"Kidney360."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:03:28Z","timestamp":1786478608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000679","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]}}}